Human Herpes Virus 6 Plasma DNA Positivity after Hematopoietic Stem Cell Transplantation in Children: an Important Risk Factor for Clinical Outcome

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 7, 2008, Pages 831-839

  Anne de Pagter, P J ^a   Schuurman, Rob ^a   Visscher, Henk ^a   de Vos, Machiel ^a   Bierings, Marc ^a   van Loon, Anton M ^a   Uiterwaal, Cuno S P M ^a   van Baarle, Debbie ^a   Sanders, Elisabeth A M ^a   Boelens, JaapJan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Children; GVHD; Hematopoietic stem cell transplantation; HHV 6; Mortality; Viral reactivation

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; BUSULFAN; CEFUROXIME; CIPROFLOXACIN; CLONAZEPAM; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; FOSCARNET SODIUM; GANCICLOVIR; METHOTREXATE; ONDANSETRON; PREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY; VALACICLOVIR; VIRUS DNA;

ACUTE GRAFT VERSUS HOST DISEASE; ADENOVIRUS; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HERPES SIMPLEX; HLA MATCHING; HUMAN; HUMAN HERPESVIRUS 6; INCIDENCE; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONITORING; MONOTHERAPY; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; UMBILICAL CORD BLOOD; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DNA, VIRAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; INFANT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 44649200413     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.04.016     Document Type: Article

References (41)

1. Wasserman R., August C.S., and Plotkin S.A. Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 7 (1988) 109-115
2. Gratama J.W., Zwaan F.E., Stijnen T., et al. Herpes-virus immunity and acute graft-versus-host disease. Lancet 1 (1987) 471-474
3. Broers A.E., van Der Holt R., van Esser J.W., et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 95 (2000) 2240-2245
4. Okuno T., Takahashi K., Balachandra K., et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 27 (1989) 651-653
5. Zerr D.M., Meier A.S., Selke S.S., et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352 (2005) 768-776
6. Zerr D.M., Corey L., Kim H.W., et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40 (2005) 932-940
7. Allen U.D., Tellier R., Doyle J., et al. The utility of plasma polymerase chain reaction for human herpes virus-6 among pediatric bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant 28 (2001) 473-477
8. Asano Y., Yoshikawa T., Suga S., et al. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia. N Engl J Med 324 (1991) 634-635
9. Savolainen H., Lautenschlager I., Piiparinen H., et al. Human herpesvirus-6 and -7 in pediatric stem cell transplantation. Pediatr Blood Cancer 45 (2005) 820-825
10. Hekker A.C., Brand-Saathof B., Vis J., and Meijers R.C. Indirect immunofluorescence test for detection of IgM antibodies to cytomegalovirus. J Infect Dis 140 (1979) 596-600
11. Watzinger F., Suda M., Preuner S., et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol 42 (2004) 5189-5198
12. Niesters H.G., van Esser J., Fries E., et al. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 38 (2000) 712-715
13. van Doornum G.J., Guldemeester J., Osterhaus A.D., and Niesters H.G. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 41 (2003) 576-580
14. Ryncarz A.J., Goddard J., Wald A., et al. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol 37 (1999) 1941-1947
15. Knoll A., Stoehr R., Jilg W., and Hartmann A. Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas. Oncol Rep 10 (2003) 487-491
16. Hawrami K., and Breuer J. Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus. J Virol Methods 79 (1999) 33-40
17. Tiercy J.M. Molecular basis of HLA polymorphism: implications in clinical transplantation. Transpl Immunol 9 (2002) 173-180
18. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
19. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
20. Hentrich M., Oruzio D., Jager G., et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 128 (2005) 66-72
21. Radonic A., Oswald O., Thulke S., et al. Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantation. Br J Haematol 131 (2005) 480-482
22. Yamane A., Mori T., Suzuki S., et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 13 (2007) 100-106
23. Wang L.R., Dong L.J., Zhang M.J., and Lu D.P. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12 (2006) 1031-1037
24. Ogata M., Kikuchi H., Satou T., et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 193 (2006) 68-79
25. Tanaka M., Taguchi J., Hyo R., et al. Human herpesvirus-6 encephalitis after unrelated cord blood transplantation. Leuk Lymphoma 46 (2005) 561-566
26. Sashihara J., Tanaka-Taya K., Tanaka S., et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100 (2002) 2005-2011
27. Tomonari A., Takahashi S., Ooi J., et al. Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation. Int J Hematol 81 (2005) 352-355
28. Feuchtinger T., Lang P., and Handgretinger R. Adenovirus infection after allogeneic stem cell transplantation. Leuk Lymphoma 48 (2007) 244-255
29. Kojaoghlanian T., Flomenberg P., and Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 13 (2003) 155-171
30. Flomenberg P., Babbitt J., Drobyski W.R., et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169 (1994) 775-781
31. Ruell J., Barnes C., Mutton K., et al. Active CMV disease does not always correlate with viral load detection. Bone Marrow Transplant 40 (2007) 55-61
32. Morris E.S., and Hill G.R. Advances in the understanding of acute graft-versus-host disease. Br J Haematol 137 (2007) 3-19
33. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 7 (2007) 340-352
34. Via C.S., Shanley J.D., and Shearer G.M. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. Analysis of in vitro T cell function. J Immunol 145 (1990) 3283-3289
35. Grivel J.C., Santoro F., Chen S., et al. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J Virol 77 (2003) 8280-8289
36. Lusso P., Markham P.D., Tschachler E., et al. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med 167 (1988) 1659-1670
37. Takahashi K., Sonoda S., Higashi K., et al. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 63 (1989) 3161-3163
38. Wang F., Yao K., Yin Q.Z., et al. Human herpesvirus-6-specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individuals. Microbiol Immunol 50 (2006) 787-803
39. Smith A., Santoro F., Di Lullo G., et al. Selective suppression of IL-12 production by human herpesvirus 6. Blood 102 (2003) 2877-2884
40. Smith A.P., Paolucci C., Di Lullo G., et al. Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol 79 (2005) 2807-2813
41. Lusso P. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J Clin Virol 37 Suppl 1 (2006) S4-S10